Solid Biosciences (SLDB) Other Non Operating Income (2017 - 2026)

Solid Biosciences has reported Other Non Operating Income for 10 years, with the latest figure at -$1.6 million in Q1 2026.

• Quarterly Other Non Operating Income changed 0.0% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 107.19% YoY) and the FY2025 annual result came in at $824000.0, up 26.38% from the prior year.
• Other Non Operating Income declined to -$1.6 million in Q1 2026 per SLDB's latest filing, from $219000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $282000.0 in Q1 2023 and troughed at -$1.6 million in Q1 2025.
• A 5-year average of -$138705.9 and a median of $199000.0 in 2024 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2023 and 2025: Other Non Operating Income soared 8933.33% in 2023, then slumped 55100.0% in 2025.
• Over 5 years, Other Non Operating Income stood at -$355000.0 in 2022, then soared by 176.06% to $270000.0 in 2023, then slipped by 26.3% to $199000.0 in 2024, then increased by 10.05% to $219000.0 in 2025, then plunged by 853.42% to -$1.6 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$1.6 million, $219000.0, and -$850000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.